Vaxart Aktie
WKN DE: A2JD8X / ISIN: US92243A2006
06.10.2021 14:25:25
|
Vaxart To Begin US Phase II Trial Of S-Only Vaccine Candidate - Quick Facts
(RTTNews) - Vaxart, Inc. (VXRT) said it has begun recruiting subjects for phase II COVID-19 oral tablet vaccine clinical trial. The company plans to begin dosing the first of 96 U.S. subjects, split evenly between COVID-19 naïve and mRNA vaccinated subjects, later this month.
The company's phase II COVID-19 program will also include countries outside of the U.S., starting with a trial in India that is anticipated to begin later in the current year.
Vaxart said new trials will generate key data that will allow it to compare the S-only and S+N vaccine candidates and help decide on the best development path forward for COVID-19 vaccine program.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vaxart Inc Registered Shsmehr Nachrichten
12.11.24 |
Ausblick: Vaxart gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Vaxart Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Vaxart Inc Registered Shs | 0,30 | -6,60% |
|